Seroatlas · Human Serome Atlas

DUSP6

Dual specificity protein phosphatase 6

Also known as: DUS6_HUMAN, MKP-3, PYST1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q16828
Gene
DUSP6
Ensembl
ENSG00000139318
Chromosome
12
Canonical length
381 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK2, is expressed in a variety of tissues with the highest levels in heart and pancreas, and unlike most other members of this family, is localized in the cytoplasm. Mutations in this gene have been associated with congenital hypogonadotropic hypogonadism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]

Canonical amino-acid sequenceUniProt

381 residues, UniProt reviewed canonical sequence.

>Q16828|DUSP6
     1  MIDTLRPVPF ASEMAISKTV AWLNEQLELG NERLLLMDCR PQELYESSHI ESAINVAIPG
    61  IMLRRLQKGN LPVRALFTRG EDRDRFTRRC GTDTVVLYDE SSSDWNENTG GESVLGLLLK
   121  KLKDEGCRAF YLEGGFSKFQ AEFSLHCETN LDGSCSSSSP PLPVLGLGGL RISSDSSSDI
   181  ESDLDRDPNS ATDSDGSPLS NSQPSFPVEI LPFLYLGCAK DSTNLDVLEE FGIKYILNVT
   241  PNLPNLFENA GEFKYKQIPI SDHWSQNLSQ FFPEAISFID EARGKNCGVL VHCLAGISRS
   301  VTVTVAYLMQ KLNLSMNDAY DIVKMKKSNI SPNFNFMGQL LDFERTLGLS SPCDNRVPAQ
   361  QLYFTTPSNQ NVYQVDSLQS T

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against DUSP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
213 nTPM

Expression across tissuesHPA

Tissue

  • salivary gland: 213 nTPM
  • bone marrow: 169 nTPM
  • liver: 134 nTPM
  • adipose tissue: 107 nTPM
  • lung: 83 nTPM
  • thyroid gland: 72 nTPM

Single-cell type

  • retinal pigment epithelial cells: 392 nCPM
  • alveolar cells type 2: 384 nCPM
  • monocytes: 380 nCPM
  • medullary thymic epithelial cells: 350 nCPM
  • mast cells: 285 nCPM
  • neutrophil progenitors: 263 nCPM

Immune cell

  • basophil: 1,643 nTPM
  • non-classical monocyte: 846 nTPM
  • intermediate monocyte: 844 nTPM
  • classical monocyte: 560 nTPM
  • total PBMC: 456 nTPM
  • eosinophil: 248 nTPM

Brain region

  • choroid plexus: 56 nTPM
  • cerebral cortex: 53 nTPM
  • hippocampal formation: 35 nTPM
  • thalamus: 28 nTPM
  • white matter: 22 nTPM
  • spinal cord: 20 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about DUSP6.

Disease | AllUniProt

Conditions DUSP6 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 100 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.26
gnomAD pLI
0.98
gnomAD missense Z
1.22
DepMap mean gene effect
0.01
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of DUSP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads DUSP6 as an antibody target. Whether an autoantibody or antibody against DUSP6 could matter depends on whether native DUSP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

DUSP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label DUSP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/DUSP6. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...